Related by context. All words. (Click for frequent words.) 72 Vitro Diagnostic IVD 71 Onko Sure TM 69 Vitro Diagnostic Multivariate 69 Oral Fluid 68 Vitro Diagnostics 68 Molecular Diagnostic Test 67 Diagnostic Tests 67 Prolongs Survival 67 Septin 9 67 Assay Kits 67 Molecular Diagnostic 66 molecular diagnostic assay 66 mSEPT9 66 Circulating Tumor Cells 66 Tumor Targeting 66 Therapeutic Monoclonal Antibodies 66 Antigen CEA 66 MammaPrint R 66 CE IVD 66 Cardiac Markers 65 Septin9 65 Infectious Disease Testing 65 Digene HPV Test 65 Onko Sure ™ 65 Quantitation 65 Genetic Tests 65 Analytical Tool 65 Glucose Monitoring 65 Situ Hybridization FISH 65 CE IVD Mark 65 Gets FDA Clearance 65 Initiate Clinical Trial 65 Protein Expression 64 DNA Methylation 64 Genetic Testing 64 Severe Sepsis 64 Companion Diagnostics 64 Nanoemulsion 64 Antitumor 64 LungAlert TM 64 Psoriasis Drug 64 Monoclonal Antibody 64 Transfection 64 Cancer Vaccines 64 Shows Promising 64 Rheumatoid Arthritis Drug 64 DNA Microarrays 64 Monoclonal Antibodies 64 Onko Sure ® 64 Vitro Diagnostic Cancer 64 Ultrasensitive 64 Interferon Alpha 64 ResponseDX ™ 64 Protein Biomarker 63 Lung Cancer Drug 63 Respiratory Virus 63 Vitro Activity 63 Seasonal Influenza Vaccine 63 Gene Expression Analysis 63 NMP# R 63 Electrophysiology Mapping 63 Squamous 63 Antimicrobial Coating 63 Pharmacogenomic 63 External Defibrillators 63 Stakeholder Opinions 63 Improves Survival 63 Therapeutic Vaccines 63 Biochip 63 Chronic Lymphocytic Leukemia 63 Contrast Agents 63 Gene Expression Profiling 63 Myelodysplastic Syndromes 63 Atopic Dermatitis 63 FDA Clearance 63 Receives Orphan Drug Designation 63 Pivotal Study 63 Novel Therapies 63 Test Detects 63 Tumor Markers 63 Rotavirus Vaccine 63 Nucleic Acid Purification 63 vitro diagnostic IVD 63 Epidermal Growth Factor Receptor 63 Immunotherapeutic 62 Antiviral Drugs 62 Improves Outcomes 62 Oncotype 62 Cancer Therapies 62 Receives Positive Opinion 62 Vaccine Candidate 62 Biomarker Study 62 FDA Clears 62 SNP Genotyping 62 Theranostics 62 Cardiac Marker 62 Breast Cancer Recurrence 62 Smooth Muscle 62 Immunoassay 62 Drug Resistant 62 Myocardial Perfusion Imaging 62 Expanded Indication 62 Companion Diagnostic 62 Files IND 62 Immunomedics Announces 62 Drug Shows Promise 62 Achieves Primary Endpoint 62 vitro diagnostic tests 62 Renal Cancer 62 Hormone Receptor Positive 62 JAK Inhibitor 62 Roche LightCycler ® 62 Recombinant Human 62 Adjuvant Treatment 62 Prognostic Value 62 Wound Dressing 62 Neoadjuvant Chemotherapy 62 Epigenomics proprietary 62 Diagnostic Testing 62 Gastric Cancer 62 Signaling Pathway 62 Proves Effective 62 Cardiotoxicity 62 TaqMan ® 62 Apoptotic 62 Lymphoid 62 Non Invasive 62 Targeted Therapy 62 Vascular Grafts 62 Combination REOLYSIN R 62 FDA Okays 62 Epitopes 62 CINtec R 62 Fungal Infections 62 Genes Involved 62 Cardiovascular Monitoring 62 FDA Approvals 62 Genetic Predisposition 62 OvPlex 62 Immunotherapies 62 Genetic Screening 62 Shows Promise Against 62 Anti infective 62 Survival Benefit 62 Stakeholder Insight 62 Oncotype DX ® 62 Renal Function 62 Situ Hybridization 62 Clinical Trial Results 62 Phase 2b Clinical Trial 62 NicAlert 62 Breast Tumors 62 Long Term Efficacy 62 Advanced Colorectal Cancer 62 Asthma Treatment 62 Tandem Mass Spectrometry 62 Transdermal Delivery 61 Combination Treatment 61 Clinical Validation 61 Immunosuppressant 61 Noninvasive Prenatal 61 Tumor Response 61 PREVU x 61 Hepatocellular Carcinoma 61 Therapeutic Antibodies 61 Tumor Marker 61 Phase 2a Trial 61 Implantable Device 61 PREVU * POC 61 Benign Prostatic Hyperplasia 61 Radient Pharmaceutical current 61 Vitro Diagnostic cancer 61 Oral Mucositis 61 Immunoassays 61 Cancer Biomarkers 61 Therapeutic Vaccine 61 Fast Track Status 61 Asthma COPD 61 Shows Efficacy 61 miRview meso 61 Clinical Outcome 61 Fecal Occult Blood 61 Initiates Clinical Trial 61 Cholesterol Lowering Drug 61 PREVU * 61 ThinPrep R 61 NICE Recommends 61 Anti Inflammatory Drug 61 Genotyping Test 61 DNAwithPap TM Test 61 Drug Candidate 61 Microarray 61 AQUA ® 61 Renal Cell Carcinoma 61 Aggressive Prostate Cancer 61 Therapeutic Potential 61 Estrogen Receptor 61 Novel Oral 61 Targeted Therapies 61 Oral Insulin 61 CupPrint R 61 Systemic Delivery 61 Combo Therapy 61 Submits NDA 61 Macrolide 61 Tyrosine Kinase Inhibitor 61 Interferon Beta 61 cobas 61 HER2 Positive 61 MiraCare TM 61 Detect Lung Cancer 61 Predictive Toxicology 61 Abbott RealTime 61 Proven Effective 61 Hsp# Inhibitor 61 Immune Cell 61 Demonstrates Potential 61 Biomarker 61 Could Detect 61 Transdermal Drug 61 Metabolic Endocrinology 61 Emerging Therapies 61 Flow Cytometry 61 Mutation Detection 61 Synthetic Peptide 61 Protein Biomarkers 61 vitro assay 61 qualitative serum 61 Treating Chronic 61 vitro diagnostic 61 RNAi Therapeutic 61 ARCHITECT HIV 61 Contrast Agent 61 PharmaVitae Profile 61 Progressive Multifocal Leukoencephalopathy 61 Prodarsan R 61 Bucindolol 61 Antibacterials 61 Oncotype DX colon cancer 61 OvaDx 61 DNA Sequencing 61 Adjuvant Chemotherapy 60 Immunogenicity 60 Rapid Detection 60 Illumina GoldenGate 60 Hepatitis B Virus 60 FDA Accepts 60 Completes Patient Enrollment 60 Neurostimulation Devices 60 Demonstrates Significant 60 Temsirolimus 60 VerifyNow 60 Pivotal Clinical Trial 60 DNAwithPap Test 60 Advanced Renal Cell 60 Randomized Clinical Trials 60 QuickVue R 60 Immune Responses 60 Calcium Acetate 60 BRACAnalysis 60 Dalbavancin 60 Salivary 60 Gene Mutation 60 NuroPro ® 60 Roche LightCycler 60 Therapy Evaluation 60 TM PCA3 60 Blood Glucose Testing 60 Small Molecule 60 Aurora Kinase 60 Roche COBAS 60 Nano Particles 60 Initiates Enrollment 60 Therapeutic Competitors Companies 60 ENLIGHT 60 VeriStrat 60 Metabolic Disorder 60 Thyroid Hormone 60 Epi proColon 60 Pulmonary Arterial Hypertension 60 Injectable Drug 60 Phase III Clinical Trial 60 Hepatitis B Vaccine 60 Cytotoxicity 60 Remote Patient Monitoring 60 Invasive Fungal Infections 60 CE Marked 60 Inflammatory Markers 60 Improved Survival 60 Cervista HPV HR 60 Multiple Myeloma Patients 60 Nicotine Vaccine 60 Toxicogenomics 60 Kidney Transplant Patients 60 FullTerm 60 Compression Therapy 60 Skin Cholesterol 60 Lung Cancer Patients 60 Metabolites 60 RPC Onko Sure 60 ImmuKnow R 60 Stem Cell Treatment 60 Tigecycline 60 Onalta TM 60 Previously Treated 60 Genetic Marker 60 Sevelamer 60 Could Predict 60 Enzyme Linked 60 AlloMap 60 Platelet Function 60 Files Patent Application 60 Progenitor Cells 60 IND Application 60 include ColorectAlert TM 60 Antiviral Therapeutics 60 Diagnostic Tools 60 Therapeutic Antibody 60 Rheumatoid Arthritis Patients 60 Drug Formulation 60 Anticancer Drug 60 Malignant Melanoma 60 Lyophilized 60 Hepatitis C Virus 60 Measurement Devices 60 Prostate Cancer Treatment 60 Phase III Trials 60 Alkaline Phosphatase 60 Soft Tissue Sarcoma 60 Antidepressant Drug 60 Vaccine Protects Against 60 Fabry Disease 60 Pulse Oximeters 60 Cell Proliferation 60 PNA FISH TM 60 Receives FDA Clearance 60 Insulin Delivery 60 TNF Blockers 60 Clinical Chemistry Analyzers 60 AnaSpec Introduces 60 Mouse Model 60 Metabolic Disease 60 Delivery Catheter 60 multiplex assays 60 Blood Pressure Monitoring 60 Assay Kit 60 Bazedoxifene 60 AlzheimAlert TM 60 Adjuvanted 60 Agilent microarrays 60 Clinical Trial Data 60 Analyte 60 Surgical Procedures 60 Topical Treatment 60 Announces FDA Clearance 60 Advanced Melanoma 60 radiotherapeutic 60 Kidney Function 60 Pivotal Phase III 60 Receives CE Marking 60 SensoLyte ™ 60 Interferon Alfa 60 Pulse Oximetry 60 Pulmonary Function 60 Drug Eluting Stent 60 BioElectronics Announces 59 Allogeneic 59 Cypher Sirolimus 59 Western Blotting 59 Acute Ischemic Stroke 59 LungSign TM 59 Blood Glucose Meters 59 ZEVALIN ® 59 HDAC Inhibitor 59 liver resection surgeries 59 Granted Orphan Drug 59 Loramyc R 59 Progenitor Cell 59 MicroRNA 59 Investigational Compound 59 Chemoprevention 59 RNAi Therapeutics 59 Analgesics 59 Arthritis Drug 59 TNF Alpha 59 Hip Implants 59 Bosutinib 59 Therapeutic Targets 59 Wound Closure 59 FAMILION ® 59 PREVU x LT 59 HemeScan 59 PROSTASCINT R 59 GenWay Biotech 59 Orphan Status 59 Safinamide 59 Diagnosis Treatment 59 BD GeneOhm 59 Breast Cancer Cells 59 Recombinant Protein 59 Multiplexed 59 microRNA profiling 59 NMP# 59 Factor Receptor 59 Predict Risk 59 Insulin Delivery Systems 59 miRview TM mets 59 Tesamorelin 59 Etravirine 59 Overactive Bladder 59 AmpliChip 59 Trastuzumab Herceptin 59 Gene Silencing 59 miRview ™ mets 59 Diabetic Nephropathy 59 Nucleic Acid Detection Immunoassay 59 Maven Semantic 59 Measurement Instruments 59 Autoimmune Disease 59 Cutaneous T 59 Disease Progression 59 Cepheid CPHD 59 Complicated Skin 59 Dx TM 59 STRIDE PD 59 Anemia Drug 59 Pirfenidone 59 Blood Clotting 59 AdnaTest 59 HCV Protease Inhibitor 59 Inflammatory Disease 59 Hypercholesterolemia 59 TB Vaccine 59 Keryx Biopharma 59 Drug Fails 59 Gastrointestinal Disorders 59 Contrast Enhanced 59 Interferon Gamma 59 Colorectal Cancer Screening 59 Raptiva R 59 multi analyte 59 RT qPCR 59 HCV genotyping 59 Mimetics 59 Protein Synthesis 59 Package Insert 59 Dry Powder Inhalers 59 Antitumor Activity 59 First Patient Treated 59 Pandemic Flu Vaccine 59 Brain Metastases 59 Bacteremia 59 Breast Cancer Treatment 59 Patients Undergoing 59 Initiates Clinical 59 Confirms Efficacy 59 Bone Metastases 59 Reduces Mortality 59 Vaccine Adjuvant 59 Artificial Pancreas 59 Preclinical Study 59 Demonstrates Potent 59 Novel Vaccine 59 Novel Antibiotic 59 Anti Angiogenesis 59 TaqMan R 59 Severe Asthma 59 BladderChek R 59 Antifungals 59 Patent Covering 59 Roche AmpliChip 59 Randomized Study 59 Influenza Virus 59 Anti Tumor 59 Solid Tumors 59 index assay IVDMIA 59 EliA 59 Receives Marketing Authorization 59 Pressure Monitoring 59 ResponseDX Lung TM 59 Stronger Warnings 59 Investigational Drug 59 DispersinB R 59 Cytometry 59 Antigen Specific 59 Lung Cancer Detection 59 Amplicor 59 ProteinChip 59 CT Angiography 59 Kinase Inhibitors 59 Commercially Available 59 AclarusDx ™ 59 bioLytical 59 NDA Submission 59 Virus Infection 59 qRT PCR 59 Teva Provides Update 59 PREVU i 59 Patient Enrollment 59 Multiparameter Patient Monitoring 59 Sestamibi 59 NASDAQ CPHD 59 Begin Clinical Trials 59 Breast Cancer Metastasis 59 Combination Therapy 59 Avian Flu Vaccine 59 Interventional Cardiology Devices 59 Transdermal Patch 59 Patients Treated With 59 Bladder Cancer 59 Iron Overload 59 Submits Supplemental 59 Eculizumab 59 Chemotherapeutic Agents 59 Preclinical Efficacy 59 Obtains CE Mark 59 Present Preclinical Data 59 Phase IIb Trial 59 Risk Stratification 59 Telatinib 59 Vaccine Adjuvants 59 Alexion Soliris 59 Capillary Electrophoresis 59 Lupus Nephritis 59 telomerase therapeutic 59 Study Shows Benefits 59 ARIXTRA R 59 C Reactive Protein 59 Novel Protein 59 PGx 59 Autoimmune Diseases 59 Receives Approvable Letter 59 Co Receptor Tropism 59 Silodosin 59 Blood Pressure Drug 59 Bone Grafts 59 Contaminated Heparin 59 Immunochemistry 59 Pandemic Influenza Vaccine 59 PREVU * LT 59 Ebola Vaccine 59 Smallpox Vaccine 59 Stem Cell Transplants 59 HepaSphere 59 Anticancer Drugs 59 Vascular Targeting Agents 59 Antigens 59 Anticoagulant 59 Cytogenetic 59 Diabetic Patients 59 Gene Mutations 59 Actimmune ® 59 Viral Load 59 Seeplex 58 Treatment Reduces 58 Detect Cancer 58 Cord Blood Stem Cells 58 Breast Tumor 58 Gene Amplification 58 Adenomas 58 Skin Irritation 58 Personalised Medicine 58 Rosetta Genomics microRNA 58 Cholesterol Drug 58 Biosimilar 58 Oxidative Stress 58 BladderChek 58 SPL# Gel vaginal microbicide 58 Vitro Diagnostics Market 58 PreGen Plus 58 Investigational Agent 58 Genomic Grade 58 diagnostic assays 58 Improve Survival 58 Randomized Phase II 58 Unapproved Drugs 58 BC SeraPro ™ 58 Personalized Immunotherapy 58 Nucleic Acids 58 Anti Infective 58 Prostate Cancer Vaccine 58 Endometrial Cancer 58 Confirmatory 58 Affymetrix GeneChip ® 58 Oligonucleotide 58 Secretase 58 Leukemias 58 IV Busulfex 58 NuroPro R 58 Vion Pharmaceuticals 58 HER2 Positive Breast Cancer 58 Mylan Receives Approval 58 Investigational Drugs 58 Cell Derived 58 Study Casts Doubt 58 Aptamer 58 Liver Fibrosis 58 Insulin Resistance 58 Unfractionated Heparin 58 Hexvix ® 58 Migraine Drug 58 Epilepsy Drug 58 Simplexa 58 FOLOTYN ® 58 Immunoassay System 58 Toxicity Testing 58 Chiral Technology 58 Chronic Lymphocytic Leukemia CLL 58 Aviptadil 58 Ovarian Cancer Patients 58 Mutation Analysis 58 Magnetic Nanoparticles 58 AstraZeneca Iressa 58 xTAG RVP 58 SIX RO ROG 58 Adjuvant Therapy 58 Luminex xTAG 58 Pepscan Therapeutics 58 Relapsed Refractory 58 Anti Tumor Activity 58 cobas ® 58 Reduced Risk 58 Cardiovascular Outcomes 58 Therapeutic Competitors Report 58 candidates Azedra 58 Low Dose 58 Pneumococcal Conjugate Vaccine 58 Genes Linked 58 Hematopoietic 58 Osteoporosis Treatment 58 Reduces Risk 58 Receives Orphan Drug 58 Nucleic Acid 58 Wound Closure Devices 58 Chemoradiation 58 Immune Cells 58 Photovoltaic Module 58 Develop Novel 58 Cervista HPV 58 Presents Preclinical Data 58 Ganciclovir 58 Raptiva ® 58 ALPCO 58 Antibody Discovery 58 Affymetrix GeneChip 58 Slow Progression 58 Biochips 58 MarketsandMarkets Global 58 Nasal Sprays 58 Tumor Cell 58 Microalbuminuria 58 Dapagliflozin 58 NADiA 58 Inhaled Insulin 58 Medullary Thyroid Cancer 58 p# antigen 58 Hexvix 58 FISH Probe 58 GRAS Status 58 Protein Interaction 58 Hormonal Therapy 58 Previously Untreated 58 Prospective Randomized 58 Single Dose 58 Gaucher Disease 58 Aridol TM 58 ColonSentry ™ 58 Pemphigus Vulgaris 58 Computer Aided Detection 58 GeneXpert R 58 Infected Patients 58 Cancer Treatments 58 Therapeutic Efficacy 58 Treatment Regimen 58 Regenerative Cells 58 IND Filing 58 gastrointestinal stromal tumors GIST 58 RNA Interference 58 Radient Pharmaceutical 58 Metastatic Melanoma 58 IVD 58 Commercialize Novel 58 Sustained Release 58 Further Validates 58 Adenoma 58 Lung Flute ® 58 Affymetrix GeneChip R 58 OVA1 ® 58 Approvable 58 OraQuick ® 58 SPECT Single Photon 58 Imaging Technique 58 Remune 58 Antisense Oligonucleotides 58 Meets Primary Endpoint 58 Granulocyte Colony Stimulating Factor 58 Pharmacogenetic 58 Cancer Incidence Mortality 58 Novel Treatments 58 Erythropoiesis Stimulating Agent 58 Shown Effective 58 Hormone Refractory Prostate Cancer 58 Cancer Stem Cells 58 preclinical efficacy 58 Hormonal Contraceptives 58 Natalizumab 58 reagent kit 58 Alternans 58 Testosterone Patch 58 mertansine 58 Recurrent Breast Cancer 58 NMP# BladderChek 58 Central Venous Catheters 58 Stem Cell Treatments 58 Mucosal 58 Lowers Risk 58 Successfully Completes Phase 58 Onalta 58 Pertuzumab 58 Adjuvant Breast Cancer 58 Investigational Treatment 58 Help Detect 58 PROGENSA R 58 Drug Eluting 58 Newly Diagnosed Multiple Myeloma 58 ERYtech Pharma 58 WavSTAT R 58 Treatment Experienced 58 First Patient Dosed 58 Phase IIb Clinical Trial 58 Pharmacokinetic Study 58 Surgical Equipment 58 Stomach Ulcer 58 IVDMIA 58 rxRNA 58 HuMax 58 Chemokine Receptor 58 antibody MAb 58 GTC recombinant human 58 Fulvestrant 58 Drug Prevents 58 INSTI TM 58 Applied Biosystems TaqMan 58 Immunodiagnostics 58 Amgen Vectibix 58 Hematological 58 ResponseDX TM 58 Lupus Drug 58 Dupuytren Contracture 58 Pooled Analysis 58 Emollient Foam 58 Lung Cancer Survival 58 Prolongs Life 58 Kinase Inhibitor 58 Blood Typing 58 miRview ™ squamous 58 Microvolt T Wave Alternans 58 Antiviral Activity 58 Pre Eclampsia 58 immunodiagnostic 58 Pralatrexate 58 Ovarian Cancer Diagnostic 58 QRT PCR 58 BREVAGen ™ 58 Dendritic Cell 58 Gliadel R 58 Biocompatibility 58 Gram Negative 58 Study Evaluating 58 Prostate Cancer Patients 58 Roche cobas 58 Genetic Mutation 58 Develops Novel 58 Pathogen Detection 58 Non Inferiority 58 Phase 1b Clinical Trial 58 Milestone Payment 58 Glatiramer Acetate 58 Drug Combo 58 IncellDx 58 Unresectable 58 ORENCIA ® 58 Glucocorticoid 58 Cytomegalovirus CMV 58 Muraglitazar 58 Nucleic Acid Testing 58 Medication Adherence 58 Microplate Readers 58 Warfarin Coumadin 58 Onalta ™ 57 BrachySil TM 57 Genes Identified 57 AFREZZA TM 57 Predict Dementia 57 Veterinary Vaccines 57 Fondaparinux 57 Chronic Hepatitis B 57 Receives Milestone Payment 57 Insulin Pumps 57 Neuroprotection 57 enzyme immunoassay EIA 57 Bacterial Infection 57 MiraCare TM Rapid 57 Nymox NX 57 Cardiovascular Devices 57 immunochemical 57 Oral Fingolimod 57 Hybrid Capture 57 Gamunex C 57 EasyCyte 57 SYCREST 57 Protein Interactions 57 Botulinum Toxin 57 Sipuleucel T 57 Anticancer Agent 57 Pregnancy Linked 57 Proteomic 57 vivo fluorescence imaging 57 Acute Heart Failure 57 Cumulase 57 Anthracycline 57 incorporate proprietary Microvolt 57 Technological Advances 57 Vidaza azacitidine 57 Ygiene TM 57 Dendritic Cells 57 DCVax 57 Cimzia ® certolizumab pegol 57 Inc Therapeutic Competitors 57 Diabetic Macular Edema 57 Serious Infections 57 Time PCR 57 Human Leukocyte Antigen 57 Monoclonal 57 reagent kits 57 Serious Side Effects 57 Endovascular Treatment 57 Immunodiagnostic 57 Significantly Improved 57 etanercept Enbrel 57 Ultra Sensitive 57 Statin Drugs 57 Hedgehog Pathway 57 Replacement Therapy 57 Antibiotic Use 57 Erectile Dysfunction Drug 57 RNA Amplification 57 Myocet 57 Pivotal Trial 57 Xolegel 57 Biopharmaceutical Manufacturing 57 SIR Spheres 57 Urinalysis 57 Gleevec Glivec 57 Enteral Feed Devices 57 Biologic Drugs 57 Xpert Flu 57 Peripheral Blood 57 MassARRAY 57 Neurodegenerative 57 Therapeutic Competitors 57 Demonstrates Sustained 57 Shows Promise 57 Breast Ultrasound 57 Novel Therapeutic 57 Estrogen Therapy 57 NMP# BladderChek Test 57 Gout Drug 57 Cyclooxygenase 2 57 Immune Mediated 57 Amniotic Fluid 57 Vaginal Gel 57 SensoLyte ® 57 NASDAQ DIGE 57 Colorectal Cancer Patients 57 Yondelis ® 57 Data Suggest 57 IDI MRSA 57 Coronary Angiography 57 INSTI 57 LC MALDI 57 Chronic Inflammation 57 Cancer Cells 57 DNA methylation markers 57 Genome Diagnostics 57 MammaPrint 57 RNA Interference RNAi 57 pancreatic enzyme replacement 57 Infusion Pumps 57 Prostate Cancer Progression 57 Cognitive Impairment 57 Advanced Prostate Cancer 57 Cell Lymphoma 57 Sample Preparation 57 ImmunoCAP ® 57 Antibiotic Resistant 57 Dose Escalation 57 NPM1 57 QPCR 57 Septin9 biomarker 57 Immunogenic 57 Rapid Antibody 57 KRAS mutation 57 Metabolomics 57 Wafer Bonding 57 Detection Device 57 Phosphatase 57 TearLab TM 57 Fixed Dose Combination 57 AxSYM 57 Antifungal 57 FDA Warns Against 57 LightCycler ® 57 D Dimer 57 IgM antibody 57 Electroporation 57 Aztreonam Lysine 57 Therapy Shows Promise 57 ORENCIA R 57 bioFILM PA TM 57 Biosensor 57 BioSante Pharmaceuticals Reports 57 Clinical Proteomics 57 Phase III Clinical Trials 57 Effectively Treats 57 Accelerated Approval 57 Laboratory Glassware 57 Diastolic Heart Failure 57 Nebulized 57 Oncotype DX TM 57 Appears Safe 57 Human Antibody 57 Potent Antiviral Activity 57 EnviroLogix 57 Gene Variation 57 Fibrinogen 57 Subtypes 57 Tumor Cells 57 Eurand NV EURX 57 Experimental Vaccine 57 Cell Differentiation 57 PCR Polymerase Chain Reaction 57 siRNA transfection 57 methylnaltrexone bromide 57 AlzheimAlert TM test 57 Fracture Risk 57 ALN HPN 57 DiLA2 57 xTAG Cystic Fibrosis 57 Daptomycin 57 Absorbable 57 Protein Linked 57 Neoplasms 57 Liver Toxicity 57 Cervical Dysplasia 57 Metastatic Colorectal Cancer 57 Catheter Associated 57 Genotypes 57 Budesonide 57 PBIO 57 DNA methylation biomarker 57 Topical Cream 57 Phase III Trial 57 ResponseDX Lung ™ 57 siRNA Delivery 57 Phase 2a Clinical Trial 57 Maven Semantic http:/www.mavensemantic.com announBruising Brandon 57 Antiviral Drug 57 Aliskiren 57 FirstCyte 57 Mutational 57 Decitabine 57 Glycosylation 57 Commonly Used 57 Pipeline Analysis 57 platform HDL Mimetic 57 ImmuKnow TM 57 Highly Potent 57 Carotid Endarterectomy 57 Bucindolol Based 57 Vitro Diagnostics IVD 57 Prostate Cancers 57 Oral Formulation 57 Universal Flu Vaccine 57 Nucleic acid 57 Liver Function 57 FUSILEV ® 57 Onko Sure 57 Left Ventricular 57 kidney urologic 57 See CLINICAL PHARMACOLOGY 57 situ hybridization FISH 57 Genotyping System 57 Helps Diagnose 57 ABBOTT PRISM 57 candidates Azedra TM 57 DNA methylation biomarkers 57 Mycobacterium tuberculosis TB 57 WavSTAT